| ENSG00000226007.2 |
NVP-TAE684 |
Breast invasive carcinoma |
0.004890525 |
Resistant |
| ENSG00000227107.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.025932415 |
Resistant |
| ENSG00000227857.2 |
NVP-TAE684 |
Breast invasive carcinoma |
0.024111339 |
Resistant |
| ENSG00000240137.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.034862321 |
Resistant |
| ENSG00000246523.3 |
NVP-TAE684 |
Breast invasive carcinoma |
0.032069048 |
Resistant |
| ENSG00000249574.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.002513866 |
Resistant |
| ENSG00000253982.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.015690284 |
Resistant |
| ENSG00000257038.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.024716019 |
Resistant |
| ENSG00000258735.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.027476265 |
Resistant |
| ENSG00000261469.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.04358606 |
Resistant |
| ENSG00000261597.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.044664023 |
Resistant |
| ENSG00000265766.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.036916275 |
Resistant |
| ENSG00000267231.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.030457509 |
Resistant |
| ENSG00000269923.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.011854719 |
Resistant |
| ENSG00000272172.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.024972896 |
Resistant |
| ENSG00000273290.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.033781713 |
Resistant |
| ENSG00000273416.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.017104942 |
Resistant |
| ENSG00000178803.6 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00925075 |
Resistant |
| ENSG00000180139.10 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040330524 |
Resistant |
| ENSG00000184068.2 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044929139 |
Resistant |
| ENSG00000197813.4 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047249095 |
Resistant |
| ENSG00000213793.3 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007226512 |
Resistant |
| ENSG00000213971.3 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021296771 |
Resistant |
| ENSG00000214401.4 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027973534 |
Resistant |
| ENSG00000219665.4 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009242374 |
Resistant |
| ENSG00000223525.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038631439 |
Resistant |
| ENSG00000223576.2 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033242692 |
Resistant |
| ENSG00000223635.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010325116 |
Resistant |
| ENSG00000225187.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018166743 |
Resistant |
| ENSG00000225335.2 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044515088 |
Resistant |
| ENSG00000226287.3 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0397161 |
Resistant |
| ENSG00000226756.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013390701 |
Resistant |
| ENSG00000226950.2 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029218383 |
Resistant |
| ENSG00000227161.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026015197 |
Resistant |
| ENSG00000227456.3 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020359974 |
Resistant |
| ENSG00000231607.4 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030387743 |
Resistant |
| ENSG00000231728.2 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001551087 |
Resistant |
| ENSG00000232593.2 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013359852 |
Resistant |
| ENSG00000232648.3 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010281486 |
Resistant |
| ENSG00000233695.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039359243 |
Resistant |
| ENSG00000234019.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007449808 |
Resistant |
| ENSG00000234327.3 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007092281 |
Resistant |
| ENSG00000235530.2 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028716012 |
Resistant |
| ENSG00000235560.3 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028982326 |
Resistant |
| ENSG00000236953.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028568741 |
Resistant |
| ENSG00000237021.2 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02458241 |
Resistant |
| ENSG00000237280.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017586459 |
Resistant |
| ENSG00000237605.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000146806 |
Resistant |
| ENSG00000237718.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020152257 |
Resistant |
| ENSG00000238058.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043012062 |
Resistant |
| ENSG00000240015.2 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015496952 |
Resistant |
| ENSG00000240211.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043399192 |
Resistant |
| ENSG00000240373.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009134506 |
Resistant |
| ENSG00000240401.4 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035023916 |
Resistant |
| ENSG00000240549.2 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018367678 |
Resistant |
| ENSG00000241163.3 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047371824 |
Resistant |
| ENSG00000242553.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019028392 |
Resistant |
| ENSG00000243433.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023598232 |
Resistant |
| ENSG00000248468.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034817461 |
Resistant |
| ENSG00000251513.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000106551 |
Resistant |
| ENSG00000253390.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032015744 |
Resistant |
| ENSG00000253653.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017456273 |
Resistant |
| ENSG00000254034.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02550322 |
Resistant |
| ENSG00000254263.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023861178 |
Resistant |
| ENSG00000254855.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01547378 |
Resistant |
| ENSG00000254907.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04463186 |
Resistant |
| ENSG00000255559.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044926955 |
Resistant |
| ENSG00000257526.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038768401 |
Resistant |
| ENSG00000258731.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016461623 |
Resistant |
| ENSG00000258824.2 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029142922 |
Resistant |
| ENSG00000259083.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029376401 |
Resistant |
| ENSG00000259172.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005127438 |
Resistant |
| ENSG00000259656.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009237893 |
Resistant |
| ENSG00000259959.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016496472 |
Resistant |
| ENSG00000260196.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024570709 |
Resistant |
| ENSG00000260260.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049948733 |
Resistant |
| ENSG00000260495.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039385415 |
Resistant |
| ENSG00000260608.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047317834 |
Resistant |
| ENSG00000260831.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026355871 |
Resistant |
| ENSG00000261131.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029407441 |
Resistant |
| ENSG00000261254.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015994435 |
Resistant |
| ENSG00000261326.2 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049007069 |
Resistant |
| ENSG00000261441.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01792106 |
Resistant |
| ENSG00000261476.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008092753 |
Resistant |
| ENSG00000261777.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005339834 |
Resistant |
| ENSG00000261886.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028072647 |
Resistant |
| ENSG00000262228.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001639643 |
Resistant |
| ENSG00000263916.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027711718 |
Resistant |
| ENSG00000264920.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036333243 |
Resistant |
| ENSG00000265656.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043932246 |
Resistant |
| ENSG00000265943.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040137148 |
Resistant |
| ENSG00000266289.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046485348 |
Resistant |
| ENSG00000267152.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018453579 |
Resistant |
| ENSG00000267167.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000935898 |
Resistant |
| ENSG00000267298.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012433426 |
Resistant |
| ENSG00000267419.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02866624 |
Resistant |
| ENSG00000267481.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040292781 |
Resistant |
| ENSG00000267751.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022094382 |
Resistant |
| ENSG00000268613.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010626852 |
Resistant |
| ENSG00000268970.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012997436 |
Resistant |
| ENSG00000269038.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019803328 |
Resistant |
| ENSG00000269107.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043120373 |
Resistant |
| ENSG00000269444.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049422976 |
Resistant |
| ENSG00000269609.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026213177 |
Resistant |
| ENSG00000269646.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017093182 |
Resistant |
| ENSG00000269825.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044282535 |
Resistant |
| ENSG00000269974.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042180519 |
Resistant |
| ENSG00000270031.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046421525 |
Resistant |
| ENSG00000270116.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034448106 |
Resistant |
| ENSG00000270159.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029176136 |
Resistant |
| ENSG00000270361.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033819183 |
Resistant |
| ENSG00000272023.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032576442 |
Resistant |
| ENSG00000272109.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034616783 |
Resistant |
| ENSG00000272630.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034928896 |
Resistant |
| ENSG00000272800.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03608217 |
Resistant |
| ENSG00000272853.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032174918 |
Resistant |
| ENSG00000273188.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026709225 |
Resistant |
| ENSG00000273343.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011982435 |
Resistant |
| ENSG00000273474.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042589474 |
Resistant |
| ENSG00000125514.5 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.033781549 |
Resistant |
| ENSG00000172250.10 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.043984063 |
Resistant |
| ENSG00000174171.4 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.037119186 |
Resistant |
| ENSG00000203307.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.029704819 |
Resistant |
| ENSG00000203356.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.010586472 |
Resistant |
| ENSG00000214546.3 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.044434295 |
Resistant |
| ENSG00000223442.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.024012903 |
Resistant |
| ENSG00000223579.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.03411434 |
Resistant |
| ENSG00000223907.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.019485161 |
Resistant |
| ENSG00000224276.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.031821868 |
Resistant |
| ENSG00000224460.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.020178672 |
Resistant |
| ENSG00000224789.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.031840822 |
Resistant |
| ENSG00000224950.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.046413395 |
Resistant |
| ENSG00000225039.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.027204026 |
Resistant |
| ENSG00000225187.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.015857096 |
Resistant |
| ENSG00000225978.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.033299597 |
Resistant |
| ENSG00000226386.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.042998875 |
Resistant |
| ENSG00000227083.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.016348905 |
Resistant |
| ENSG00000227192.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.033125477 |
Resistant |
| ENSG00000227218.3 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.047821767 |
Resistant |
| ENSG00000227486.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.030739285 |
Resistant |
| ENSG00000227857.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.020133025 |
Resistant |
| ENSG00000228079.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.02021225 |
Resistant |
| ENSG00000228113.3 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.032103133 |
Resistant |
| ENSG00000228487.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.013571106 |
Resistant |
| ENSG00000228682.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.030077805 |
Resistant |
| ENSG00000229017.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.037462764 |
Resistant |
| ENSG00000229431.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.030115603 |
Resistant |
| ENSG00000229848.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.023007556 |
Resistant |
| ENSG00000230138.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.036002924 |
Resistant |
| ENSG00000230896.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.011525335 |
Resistant |
| ENSG00000231133.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.032088141 |
Resistant |
| ENSG00000231509.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.048589035 |
Resistant |
| ENSG00000231651.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.038738738 |
Resistant |
| ENSG00000232618.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.009128269 |
Resistant |
| ENSG00000232710.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.037012968 |
Resistant |
| ENSG00000232807.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.035172464 |
Resistant |
| ENSG00000232912.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.032117209 |
Resistant |
| ENSG00000233178.3 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.030943605 |
Resistant |
| ENSG00000233207.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.044848234 |
Resistant |
| ENSG00000233411.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.027809082 |
Resistant |
| ENSG00000233554.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.047643427 |
Resistant |
| ENSG00000233627.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.010182271 |
Resistant |
| ENSG00000234141.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.03743002 |
Resistant |
| ENSG00000234504.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.040787595 |
Resistant |
| ENSG00000234617.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.047795627 |
Resistant |
| ENSG00000234622.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.032106845 |
Resistant |
| ENSG00000234884.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.030826486 |
Resistant |
| ENSG00000235052.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.00587613 |
Resistant |
| ENSG00000235652.3 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.039018042 |
Resistant |
| ENSG00000235706.3 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.047198605 |
Resistant |
| ENSG00000236066.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.022281943 |
Resistant |
| ENSG00000237036.4 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.047341091 |
Resistant |
| ENSG00000237588.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.021481768 |
Resistant |
| ENSG00000237877.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.015740186 |
Resistant |
| ENSG00000237980.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.039900929 |
Resistant |
| ENSG00000238198.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.039044846 |
Resistant |
| ENSG00000238280.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.028082596 |
Resistant |
| ENSG00000239377.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.029825428 |
Resistant |
| ENSG00000240476.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.039594701 |
Resistant |
| ENSG00000240770.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.049327624 |
Resistant |
| ENSG00000241042.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.044497399 |
Resistant |
| ENSG00000241163.3 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.040585309 |
Resistant |
| ENSG00000245146.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.047659241 |
Resistant |
| ENSG00000246375.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.045153395 |
Resistant |
| ENSG00000247774.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.019864164 |
Resistant |
| ENSG00000248152.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.031246749 |
Resistant |
| ENSG00000248399.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.043157384 |
Resistant |
| ENSG00000249417.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.033496127 |
Resistant |
| ENSG00000249685.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.012173682 |
Resistant |
| ENSG00000250159.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.044568831 |
Resistant |
| ENSG00000250910.3 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.047623225 |
Resistant |
| ENSG00000251034.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.036669782 |
Resistant |
| ENSG00000251661.3 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.006260722 |
Resistant |
| ENSG00000251687.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.025835089 |
Resistant |
| ENSG00000253921.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.000803753 |
Resistant |
| ENSG00000254099.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.040711414 |
Resistant |
| ENSG00000254662.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.021034161 |
Resistant |
| ENSG00000254718.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.047652987 |
Resistant |
| ENSG00000254910.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.007927015 |
Resistant |
| ENSG00000255089.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.011360995 |
Resistant |
| ENSG00000255354.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.042171901 |
Resistant |
| ENSG00000255458.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.019400277 |
Resistant |
| ENSG00000257135.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.0350754 |
Resistant |
| ENSG00000257947.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.041869886 |
Resistant |
| ENSG00000258001.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.011450319 |
Resistant |
| ENSG00000258096.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.04929871 |
Resistant |
| ENSG00000258181.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.047393003 |
Resistant |
| ENSG00000258260.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.025421706 |
Resistant |
| ENSG00000258325.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.033193515 |
Resistant |
| ENSG00000258545.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.038019014 |
Resistant |
| ENSG00000258940.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.032771779 |
Resistant |
| ENSG00000259153.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.013228397 |
Resistant |
| ENSG00000259439.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.044201414 |
Resistant |
| ENSG00000259536.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.049636991 |
Resistant |
| ENSG00000259577.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.028951555 |
Resistant |
| ENSG00000259598.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.034968223 |
Resistant |
| ENSG00000259772.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.036349631 |
Resistant |
| ENSG00000259899.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.046042231 |
Resistant |
| ENSG00000260186.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.027643122 |
Resistant |
| ENSG00000260398.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.038517609 |
Resistant |
| ENSG00000260805.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.021405403 |
Resistant |
| ENSG00000260831.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.023228527 |
Resistant |
| ENSG00000260912.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.015326802 |
Resistant |
| ENSG00000260948.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.031298738 |
Resistant |
| ENSG00000261019.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.012626384 |
Resistant |
| ENSG00000261173.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.024757953 |
Resistant |
| ENSG00000261386.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.009339702 |
Resistant |
| ENSG00000261416.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.044483672 |
Resistant |
| ENSG00000261512.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.027067425 |
Resistant |
| ENSG00000261731.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.045599997 |
Resistant |
| ENSG00000262903.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.010571811 |
Resistant |
| ENSG00000263050.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.023237158 |
Resistant |
| ENSG00000263164.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.047779193 |
Resistant |
| ENSG00000263874.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.049767206 |
Resistant |
| ENSG00000264043.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.017261259 |
Resistant |
| ENSG00000267010.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.033430814 |
Resistant |
| ENSG00000267138.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.037895321 |
Resistant |
| ENSG00000267278.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.009303753 |
Resistant |
| ENSG00000267395.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.01434097 |
Resistant |
| ENSG00000267638.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.034815909 |
Resistant |
| ENSG00000267705.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.03628626 |
Resistant |
| ENSG00000267709.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.028428721 |
Resistant |
| ENSG00000267711.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.021015017 |
Resistant |
| ENSG00000268066.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.04689281 |
Resistant |
| ENSG00000268199.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.021503671 |
Resistant |
| ENSG00000269425.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.020220665 |
Resistant |
| ENSG00000269481.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.022909099 |
Resistant |
| ENSG00000269680.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.033854071 |
Resistant |
| ENSG00000270105.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.018588762 |
Resistant |
| ENSG00000270157.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.043333065 |
Resistant |
| ENSG00000270659.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.009824342 |
Resistant |
| ENSG00000271752.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.00946505 |
Resistant |
| ENSG00000272264.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.028216905 |
Resistant |
| ENSG00000272275.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.038809385 |
Resistant |
| ENSG00000272567.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.035459977 |
Resistant |
| ENSG00000272832.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.040192088 |
Resistant |
| ENSG00000272864.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.040739786 |
Resistant |
| ENSG00000273118.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.029070113 |
Resistant |
| ENSG00000273179.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.043019176 |
Resistant |
| ENSG00000273305.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.04663197 |
Resistant |
| ENSG00000273308.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.036385505 |
Resistant |
| ENSG00000273319.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.034773665 |
Resistant |
| ENSG00000273474.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.004603734 |
Resistant |
| ENSG00000186615.6 |
NVP-TAE684 |
Brain lower grade glioma |
0.007647935 |
Resistant |
| ENSG00000189223.9 |
NVP-TAE684 |
Brain lower grade glioma |
0.048528945 |
Resistant |
| ENSG00000204241.3 |
NVP-TAE684 |
Brain lower grade glioma |
0.008852676 |
Resistant |
| ENSG00000214725.3 |
NVP-TAE684 |
Brain lower grade glioma |
0.02036893 |
Resistant |
| ENSG00000223356.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.04799104 |
Resistant |
| ENSG00000224079.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.036671056 |
Resistant |
| ENSG00000224616.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.043153303 |
Resistant |
| ENSG00000224738.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.037842281 |
Resistant |
| ENSG00000225113.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.005233451 |
Resistant |
| ENSG00000226824.2 |
NVP-TAE684 |
Brain lower grade glioma |
0.043407314 |
Resistant |
| ENSG00000227245.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.044133799 |
Resistant |
| ENSG00000227409.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.020779696 |
Resistant |
| ENSG00000227540.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.001199707 |
Resistant |
| ENSG00000230612.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.041252157 |
Resistant |
| ENSG00000230736.2 |
NVP-TAE684 |
Brain lower grade glioma |
0.039748339 |
Resistant |
| ENSG00000231611.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.006870946 |
Resistant |
| ENSG00000231993.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.017644241 |
Resistant |
| ENSG00000232093.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.015696912 |
Resistant |
| ENSG00000232442.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.049750493 |
Resistant |
| ENSG00000234665.4 |
NVP-TAE684 |
Brain lower grade glioma |
0.037341592 |
Resistant |
| ENSG00000235488.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.049653819 |
Resistant |
| ENSG00000235703.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.017992604 |
Resistant |
| ENSG00000235954.2 |
NVP-TAE684 |
Brain lower grade glioma |
0.041383936 |
Resistant |
| ENSG00000236810.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.041098573 |
Resistant |
| ENSG00000237737.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.015833839 |
Resistant |
| ENSG00000239213.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.016471523 |
Resistant |
| ENSG00000239569.2 |
NVP-TAE684 |
Brain lower grade glioma |
0.035865807 |
Resistant |
| ENSG00000239608.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.046117241 |
Resistant |
| ENSG00000240549.2 |
NVP-TAE684 |
Brain lower grade glioma |
0.046350891 |
Resistant |
| ENSG00000241769.3 |
NVP-TAE684 |
Brain lower grade glioma |
0.046123607 |
Resistant |
| ENSG00000241954.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.049086815 |
Resistant |
| ENSG00000243018.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.030432582 |
Resistant |
| ENSG00000243389.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.042022195 |
Resistant |
| ENSG00000244184.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.045744418 |
Resistant |
| ENSG00000245729.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.041485261 |
Resistant |
| ENSG00000247092.2 |
NVP-TAE684 |
Brain lower grade glioma |
0.040522496 |
Resistant |
| ENSG00000247675.2 |
NVP-TAE684 |
Brain lower grade glioma |
0.004288285 |
Resistant |
| ENSG00000248668.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.003969093 |
Resistant |
| ENSG00000250122.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.002280779 |
Resistant |
| ENSG00000250337.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.015866531 |
Resistant |
| ENSG00000254964.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.022700706 |
Resistant |
| ENSG00000255153.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.032318762 |
Resistant |
| ENSG00000255670.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.034269872 |
Resistant |
| ENSG00000256442.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.005265347 |
Resistant |
| ENSG00000257953.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.025485422 |
Resistant |
| ENSG00000258301.2 |
NVP-TAE684 |
Brain lower grade glioma |
0.010411208 |
Resistant |
| ENSG00000258620.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.003220144 |
Resistant |
| ENSG00000259251.2 |
NVP-TAE684 |
Brain lower grade glioma |
0.025823572 |
Resistant |
| ENSG00000259442.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.020416221 |
Resistant |
| ENSG00000259499.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.042901231 |
Resistant |
| ENSG00000259994.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.025157459 |
Resistant |
| ENSG00000260091.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.008079514 |
Resistant |
| ENSG00000260233.2 |
NVP-TAE684 |
Brain lower grade glioma |
0.0000503 |
Resistant |
| ENSG00000260269.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.013009971 |
Resistant |
| ENSG00000260276.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.045378627 |
Resistant |
| ENSG00000260920.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.026523828 |
Resistant |
| ENSG00000260924.2 |
NVP-TAE684 |
Brain lower grade glioma |
0.039831491 |
Resistant |
| ENSG00000260948.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.012050594 |
Resistant |
| ENSG00000261355.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.036635868 |
Resistant |
| ENSG00000261879.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.042573148 |
Resistant |
| ENSG00000262837.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.000190927 |
Resistant |
| ENSG00000263164.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.040139781 |
Resistant |
| ENSG00000265399.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.004305731 |
Resistant |
| ENSG00000265542.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.0254068 |
Resistant |
| ENSG00000267834.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.034090137 |
Resistant |
| ENSG00000268683.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.041774657 |
Resistant |
| ENSG00000268836.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.040673646 |
Resistant |
| ENSG00000269386.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.000345386 |
Resistant |
| ENSG00000269653.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.030202966 |
Resistant |
| ENSG00000269893.2 |
NVP-TAE684 |
Brain lower grade glioma |
0.013140822 |
Resistant |
| ENSG00000269947.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.017707796 |
Resistant |
| ENSG00000269979.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.002227202 |
Resistant |
| ENSG00000270344.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.032937512 |
Resistant |
| ENSG00000271151.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.020314564 |
Resistant |
| ENSG00000271789.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.017827579 |
Resistant |
| ENSG00000271889.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.011457025 |
Resistant |
| ENSG00000271964.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.011118917 |
Resistant |
| ENSG00000272508.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.044651103 |
Resistant |
| ENSG00000272644.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.044969516 |
Resistant |
| ENSG00000272688.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.011108741 |
Resistant |
| ENSG00000272702.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.033423523 |
Resistant |
| ENSG00000273449.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.00519564 |
Resistant |
| ENSG00000178947.8 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.016679988 |
Resistant |
| ENSG00000196421.3 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.01536877 |
Resistant |
| ENSG00000203849.6 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.048324787 |
Resistant |
| ENSG00000205663.5 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.039057203 |
Resistant |
| ENSG00000214870.4 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.045865975 |
Resistant |
| ENSG00000223379.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.016377352 |
Resistant |
| ENSG00000225446.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.027629032 |
Resistant |
| ENSG00000225572.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.024111043 |
Resistant |
| ENSG00000226276.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.014482932 |
Resistant |
| ENSG00000227373.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.048936465 |
Resistant |
| ENSG00000227704.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.009692457 |
Resistant |
| ENSG00000228079.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.027936921 |
Resistant |
| ENSG00000228544.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.010901799 |
Resistant |
| ENSG00000228973.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.012147026 |
Resistant |
| ENSG00000229111.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.014312688 |
Resistant |
| ENSG00000229582.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.04645179 |
Resistant |
| ENSG00000229956.5 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.011649774 |
Resistant |
| ENSG00000230735.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.02174846 |
Resistant |
| ENSG00000230747.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.039039363 |
Resistant |
| ENSG00000230826.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.021301271 |
Resistant |
| ENSG00000230880.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.030117294 |
Resistant |
| ENSG00000231964.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.038658132 |
Resistant |
| ENSG00000231993.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.02041647 |
Resistant |
| ENSG00000231999.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.019020767 |
Resistant |
| ENSG00000232640.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.00558154 |
Resistant |
| ENSG00000234917.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.028659415 |
Resistant |
| ENSG00000235660.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.02264642 |
Resistant |
| ENSG00000236901.3 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.015112939 |
Resistant |
| ENSG00000249602.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.024903533 |
Resistant |
| ENSG00000250734.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.033571183 |
Resistant |
| ENSG00000251161.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.025175657 |
Resistant |
| ENSG00000253335.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.018926094 |
Resistant |
| ENSG00000253878.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.022150587 |
Resistant |
| ENSG00000254538.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.00482553 |
Resistant |
| ENSG00000254560.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.030574956 |
Resistant |
| ENSG00000254855.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.049602623 |
Resistant |
| ENSG00000257568.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.031031642 |
Resistant |
| ENSG00000258609.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.031722206 |
Resistant |
| ENSG00000259377.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.041581393 |
Resistant |
| ENSG00000259407.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.040842203 |
Resistant |
| ENSG00000259959.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.009543459 |
Resistant |
| ENSG00000260060.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.025560883 |
Resistant |
| ENSG00000260063.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.020881794 |
Resistant |
| ENSG00000260360.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.043913226 |
Resistant |
| ENSG00000260509.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.034102612 |
Resistant |
| ENSG00000261428.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.036815579 |
Resistant |
| ENSG00000261447.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.02940966 |
Resistant |
| ENSG00000261996.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.031111225 |
Resistant |
| ENSG00000262202.3 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.042389353 |
Resistant |
| ENSG00000262339.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.031505662 |
Resistant |
| ENSG00000263098.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.046868778 |
Resistant |
| ENSG00000265130.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.026816067 |
Resistant |
| ENSG00000265242.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.033457355 |
Resistant |
| ENSG00000266844.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.020530533 |
Resistant |
| ENSG00000266918.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.001235767 |
Resistant |
| ENSG00000267040.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.03671047 |
Resistant |
| ENSG00000270124.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.044418683 |
Resistant |
| ENSG00000270361.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.038232439 |
Resistant |
| ENSG00000270457.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.044789605 |
Resistant |
| ENSG00000270742.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.035306272 |
Resistant |
| ENSG00000271185.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.025043684 |
Resistant |
| ENSG00000271927.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.043880678 |
Resistant |
| ENSG00000272004.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.030661388 |
Resistant |
| ENSG00000272516.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.033139971 |
Resistant |
| ENSG00000272650.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.035590781 |
Resistant |
| ENSG00000272754.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.011373555 |
Resistant |
| ENSG00000272871.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.031668713 |
Resistant |
| ENSG00000272911.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.030889823 |
Resistant |
| ENSG00000272995.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.042953823 |
Resistant |
| ENSG00000180846.4 |
NVP-TAE684 |
Breast invasive carcinoma |
0.02751852 |
Sensitive |
| ENSG00000204706.10 |
NVP-TAE684 |
Breast invasive carcinoma |
0.004508809 |
Sensitive |
| ENSG00000225218.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.009801206 |
Sensitive |
| ENSG00000225484.2 |
NVP-TAE684 |
Breast invasive carcinoma |
0.033167035 |
Sensitive |
| ENSG00000225806.3 |
NVP-TAE684 |
Breast invasive carcinoma |
0.027312518 |
Sensitive |
| ENSG00000225945.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.033722356 |
Sensitive |
| ENSG00000226833.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.003165419 |
Sensitive |
| ENSG00000227512.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.039887522 |
Sensitive |
| ENSG00000228302.2 |
NVP-TAE684 |
Breast invasive carcinoma |
0.009588128 |
Sensitive |
| ENSG00000228509.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.03696677 |
Sensitive |
| ENSG00000229692.3 |
NVP-TAE684 |
Breast invasive carcinoma |
0.029139268 |
Sensitive |
| ENSG00000230176.2 |
NVP-TAE684 |
Breast invasive carcinoma |
0.046159894 |
Sensitive |
| ENSG00000230615.2 |
NVP-TAE684 |
Breast invasive carcinoma |
0.024176629 |
Sensitive |
| ENSG00000231104.4 |
NVP-TAE684 |
Breast invasive carcinoma |
0.035184365 |
Sensitive |
| ENSG00000231329.3 |
NVP-TAE684 |
Breast invasive carcinoma |
0.04178936 |
Sensitive |
| ENSG00000231760.2 |
NVP-TAE684 |
Breast invasive carcinoma |
0.023042719 |
Sensitive |
| ENSG00000232116.2 |
NVP-TAE684 |
Breast invasive carcinoma |
0.018749811 |
Sensitive |
| ENSG00000233144.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.033413461 |
Sensitive |
| ENSG00000233593.2 |
NVP-TAE684 |
Breast invasive carcinoma |
0.04993173 |
Sensitive |
| ENSG00000233602.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.035379252 |
Sensitive |
| ENSG00000233783.3 |
NVP-TAE684 |
Breast invasive carcinoma |
0.04710774 |
Sensitive |
| ENSG00000234477.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.04303063 |
Sensitive |
| ENSG00000234753.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.011800112 |
Sensitive |
| ENSG00000235146.2 |
NVP-TAE684 |
Breast invasive carcinoma |
0.031390418 |
Sensitive |
| ENSG00000235703.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.016154962 |
Sensitive |
| ENSG00000237128.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.034032055 |
Sensitive |
| ENSG00000237491.4 |
NVP-TAE684 |
Breast invasive carcinoma |
0.007227885 |
Sensitive |
| ENSG00000237705.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.012124148 |
Sensitive |
| ENSG00000237938.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.041103309 |
Sensitive |
| ENSG00000244733.4 |
NVP-TAE684 |
Breast invasive carcinoma |
0.030648006 |
Sensitive |
| ENSG00000249532.2 |
NVP-TAE684 |
Breast invasive carcinoma |
0.034083968 |
Sensitive |
| ENSG00000250950.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.03440723 |
Sensitive |
| ENSG00000251555.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.014721781 |
Sensitive |
| ENSG00000254165.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.025747673 |
Sensitive |
| ENSG00000254461.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.021575337 |
Sensitive |
| ENSG00000256603.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.046145782 |
Sensitive |
| ENSG00000261002.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.024614271 |
Sensitive |
| ENSG00000261386.2 |
NVP-TAE684 |
Breast invasive carcinoma |
0.037448676 |
Sensitive |
| ENSG00000264859.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.014211241 |
Sensitive |
| ENSG00000265750.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.024819969 |
Sensitive |
| ENSG00000266538.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.015079652 |
Sensitive |
| ENSG00000266897.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.033277506 |
Sensitive |
| ENSG00000266936.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.008473354 |
Sensitive |
| ENSG00000267096.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.02449447 |
Sensitive |
| ENSG00000267143.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.015487157 |
Sensitive |
| ENSG00000267212.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.047637395 |
Sensitive |
| ENSG00000267759.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.023428346 |
Sensitive |
| ENSG00000269444.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.02471568 |
Sensitive |
| ENSG00000269825.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.014910766 |
Sensitive |
| ENSG00000270426.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.026404122 |
Sensitive |
| ENSG00000272338.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.021165162 |
Sensitive |
| ENSG00000272438.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.026653228 |
Sensitive |
| ENSG00000272864.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.001624486 |
Sensitive |
| ENSG00000273139.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.041794409 |
Sensitive |
| ENSG00000273188.1 |
NVP-TAE684 |
Breast invasive carcinoma |
0.018366219 |
Sensitive |
| ENSG00000204054.7 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014863281 |
Sensitive |
| ENSG00000205885.3 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017601533 |
Sensitive |
| ENSG00000215241.3 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026944106 |
Sensitive |
| ENSG00000224577.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000218737 |
Sensitive |
| ENSG00000225177.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039597523 |
Sensitive |
| ENSG00000225361.3 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021386926 |
Sensitive |
| ENSG00000225963.3 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037561953 |
Sensitive |
| ENSG00000225986.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022351783 |
Sensitive |
| ENSG00000227512.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039917605 |
Sensitive |
| ENSG00000228022.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047243509 |
Sensitive |
| ENSG00000228223.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030376603 |
Sensitive |
| ENSG00000229951.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038334941 |
Sensitive |
| ENSG00000230013.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026509999 |
Sensitive |
| ENSG00000230542.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041320138 |
Sensitive |
| ENSG00000230613.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01865873 |
Sensitive |
| ENSG00000230736.2 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043426985 |
Sensitive |
| ENSG00000231312.2 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018298958 |
Sensitive |
| ENSG00000231948.2 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022045824 |
Sensitive |
| ENSG00000232518.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045421484 |
Sensitive |
| ENSG00000232542.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045423193 |
Sensitive |
| ENSG00000233509.2 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01992052 |
Sensitive |
| ENSG00000233593.2 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003715136 |
Sensitive |
| ENSG00000234871.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046075189 |
Sensitive |
| ENSG00000235092.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045990594 |
Sensitive |
| ENSG00000235192.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01852961 |
Sensitive |
| ENSG00000235385.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049663402 |
Sensitive |
| ENSG00000236383.3 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016763573 |
Sensitive |
| ENSG00000237357.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012400899 |
Sensitive |
| ENSG00000241449.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026825882 |
Sensitive |
| ENSG00000241954.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031763363 |
Sensitive |
| ENSG00000242154.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044167995 |
Sensitive |
| ENSG00000244513.2 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03946862 |
Sensitive |
| ENSG00000247345.2 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048400067 |
Sensitive |
| ENSG00000248254.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032092315 |
Sensitive |
| ENSG00000250049.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021987013 |
Sensitive |
| ENSG00000250899.3 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040077726 |
Sensitive |
| ENSG00000251010.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012447832 |
Sensitive |
| ENSG00000254237.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004135033 |
Sensitive |
| ENSG00000254419.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013651811 |
Sensitive |
| ENSG00000255328.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033145818 |
Sensitive |
| ENSG00000256967.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008249674 |
Sensitive |
| ENSG00000257556.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015008067 |
Sensitive |
| ENSG00000257759.2 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024447605 |
Sensitive |
| ENSG00000258086.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038719652 |
Sensitive |
| ENSG00000258733.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001688755 |
Sensitive |
| ENSG00000258940.2 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04492231 |
Sensitive |
| ENSG00000259703.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030894327 |
Sensitive |
| ENSG00000259867.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010720318 |
Sensitive |
| ENSG00000260052.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030325199 |
Sensitive |
| ENSG00000260336.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034478393 |
Sensitive |
| ENSG00000261353.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031909921 |
Sensitive |
| ENSG00000262098.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002253627 |
Sensitive |
| ENSG00000263612.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002324686 |
Sensitive |
| ENSG00000265490.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003081 |
Sensitive |
| ENSG00000266340.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019266792 |
Sensitive |
| ENSG00000266903.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03207879 |
Sensitive |
| ENSG00000267375.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018876045 |
Sensitive |
| ENSG00000269720.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02395496 |
Sensitive |
| ENSG00000270090.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049901704 |
Sensitive |
| ENSG00000270681.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047275219 |
Sensitive |
| ENSG00000270972.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041481755 |
Sensitive |
| ENSG00000271020.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0000971 |
Sensitive |
| ENSG00000271324.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001014335 |
Sensitive |
| ENSG00000271643.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00126231 |
Sensitive |
| ENSG00000271778.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024777337 |
Sensitive |
| ENSG00000272949.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026565729 |
Sensitive |
| ENSG00000273305.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013329925 |
Sensitive |
| ENSG00000273319.1 |
NVP-TAE684 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047746357 |
Sensitive |
| ENSG00000225195.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.037660083 |
Sensitive |
| ENSG00000225703.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.041764014 |
Sensitive |
| ENSG00000228817.3 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.010224774 |
Sensitive |
| ENSG00000229278.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.03201811 |
Sensitive |
| ENSG00000229401.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.019898748 |
Sensitive |
| ENSG00000231705.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.006877128 |
Sensitive |
| ENSG00000236643.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.046977325 |
Sensitive |
| ENSG00000238133.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.006031413 |
Sensitive |
| ENSG00000242474.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.037833691 |
Sensitive |
| ENSG00000243533.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.019177575 |
Sensitive |
| ENSG00000244332.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.026451151 |
Sensitive |
| ENSG00000250267.2 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.01533729 |
Sensitive |
| ENSG00000253930.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.018475731 |
Sensitive |
| ENSG00000254988.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.021493855 |
Sensitive |
| ENSG00000256783.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.027213272 |
Sensitive |
| ENSG00000257097.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.048781617 |
Sensitive |
| ENSG00000257105.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.024435292 |
Sensitive |
| ENSG00000257507.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.01072352 |
Sensitive |
| ENSG00000258268.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.014447583 |
Sensitive |
| ENSG00000259469.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.03230901 |
Sensitive |
| ENSG00000259617.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.01340539 |
Sensitive |
| ENSG00000259999.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.014738252 |
Sensitive |
| ENSG00000262339.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.022506496 |
Sensitive |
| ENSG00000266579.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.039991393 |
Sensitive |
| ENSG00000267475.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.040276282 |
Sensitive |
| ENSG00000267488.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.036691951 |
Sensitive |
| ENSG00000269902.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.002454161 |
Sensitive |
| ENSG00000270069.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.025076893 |
Sensitive |
| ENSG00000270951.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.031688709 |
Sensitive |
| ENSG00000271840.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.048581643 |
Sensitive |
| ENSG00000272142.1 |
NVP-TAE684 |
Chronic Lymphocytic Leukemia |
0.024534637 |
Sensitive |
| ENSG00000187229.3 |
NVP-TAE684 |
Brain lower grade glioma |
0.003067188 |
Sensitive |
| ENSG00000223855.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.019690599 |
Sensitive |
| ENSG00000223975.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.035754418 |
Sensitive |
| ENSG00000224376.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.018910782 |
Sensitive |
| ENSG00000224533.3 |
NVP-TAE684 |
Brain lower grade glioma |
0.020121818 |
Sensitive |
| ENSG00000225285.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.031239659 |
Sensitive |
| ENSG00000225956.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.00512391 |
Sensitive |
| ENSG00000228470.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.002276203 |
Sensitive |
| ENSG00000229267.2 |
NVP-TAE684 |
Brain lower grade glioma |
0.025184573 |
Sensitive |
| ENSG00000229841.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.036782472 |
Sensitive |
| ENSG00000230630.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.00000256 |
Sensitive |
| ENSG00000231770.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.048941227 |
Sensitive |
| ENSG00000232227.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.000448715 |
Sensitive |
| ENSG00000232642.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.010480845 |
Sensitive |
| ENSG00000232814.2 |
NVP-TAE684 |
Brain lower grade glioma |
0.012207035 |
Sensitive |
| ENSG00000233785.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.041912316 |
Sensitive |
| ENSG00000233893.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.04722912 |
Sensitive |
| ENSG00000235027.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.013256084 |
Sensitive |
| ENSG00000236166.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.04194856 |
Sensitive |
| ENSG00000237152.2 |
NVP-TAE684 |
Brain lower grade glioma |
0.023366367 |
Sensitive |
| ENSG00000239219.2 |
NVP-TAE684 |
Brain lower grade glioma |
0.030967986 |
Sensitive |
| ENSG00000240063.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.028923727 |
Sensitive |
| ENSG00000248266.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.009345127 |
Sensitive |
| ENSG00000250303.2 |
NVP-TAE684 |
Brain lower grade glioma |
0.001104146 |
Sensitive |
| ENSG00000250320.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.02492699 |
Sensitive |
| ENSG00000251603.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.031792636 |
Sensitive |
| ENSG00000253955.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.006771232 |
Sensitive |
| ENSG00000254267.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.032740199 |
Sensitive |
| ENSG00000255580.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.048134324 |
Sensitive |
| ENSG00000259408.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.004899582 |
Sensitive |
| ENSG00000260693.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.00139825 |
Sensitive |
| ENSG00000260698.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.002503741 |
Sensitive |
| ENSG00000260796.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.042180578 |
Sensitive |
| ENSG00000260830.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.00979223 |
Sensitive |
| ENSG00000260841.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.035576763 |
Sensitive |
| ENSG00000261064.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.006972764 |
Sensitive |
| ENSG00000261888.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.000107657 |
Sensitive |
| ENSG00000262434.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.045571357 |
Sensitive |
| ENSG00000264968.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.00545446 |
Sensitive |
| ENSG00000266930.2 |
NVP-TAE684 |
Brain lower grade glioma |
0.046472624 |
Sensitive |
| ENSG00000267395.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.007956589 |
Sensitive |
| ENSG00000269924.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.045976789 |
Sensitive |
| ENSG00000269936.2 |
NVP-TAE684 |
Brain lower grade glioma |
0.006215086 |
Sensitive |
| ENSG00000271826.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.029743824 |
Sensitive |
| ENSG00000272129.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.037685422 |
Sensitive |
| ENSG00000272209.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.027326533 |
Sensitive |
| ENSG00000272265.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.026306234 |
Sensitive |
| ENSG00000272482.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.048215561 |
Sensitive |
| ENSG00000272761.1 |
NVP-TAE684 |
Brain lower grade glioma |
0.017060092 |
Sensitive |
| ENSG00000031544.10 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.049791498 |
Sensitive |
| ENSG00000124915.6 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.02887755 |
Sensitive |
| ENSG00000172965.10 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.004058806 |
Sensitive |
| ENSG00000188477.8 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.035185778 |
Sensitive |
| ENSG00000203801.4 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.034336843 |
Sensitive |
| ENSG00000204011.4 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.000395904 |
Sensitive |
| ENSG00000204362.5 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.036829021 |
Sensitive |
| ENSG00000205885.3 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.034057299 |
Sensitive |
| ENSG00000221817.5 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.00026769 |
Sensitive |
| ENSG00000223477.3 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.031130106 |
Sensitive |
| ENSG00000223829.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.034472134 |
Sensitive |
| ENSG00000224609.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.03475755 |
Sensitive |
| ENSG00000225187.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.01857528 |
Sensitive |
| ENSG00000225361.3 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.025646132 |
Sensitive |
| ENSG00000225434.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.049511563 |
Sensitive |
| ENSG00000225760.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.027847926 |
Sensitive |
| ENSG00000225764.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.041784599 |
Sensitive |
| ENSG00000225963.3 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.010582456 |
Sensitive |
| ENSG00000226312.3 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.034986716 |
Sensitive |
| ENSG00000226548.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.044292022 |
Sensitive |
| ENSG00000226574.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.035067196 |
Sensitive |
| ENSG00000227496.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.028673163 |
Sensitive |
| ENSG00000228261.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.043165759 |
Sensitive |
| ENSG00000228322.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.037545394 |
Sensitive |
| ENSG00000228352.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.044176199 |
Sensitive |
| ENSG00000229261.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.014100344 |
Sensitive |
| ENSG00000229356.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.028422947 |
Sensitive |
| ENSG00000229463.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.029023383 |
Sensitive |
| ENSG00000229931.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.042585272 |
Sensitive |
| ENSG00000229951.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.006769429 |
Sensitive |
| ENSG00000230001.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.007161884 |
Sensitive |
| ENSG00000230084.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.017699356 |
Sensitive |
| ENSG00000230479.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.009375771 |
Sensitive |
| ENSG00000230812.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.040504086 |
Sensitive |
| ENSG00000231290.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.011431234 |
Sensitive |
| ENSG00000231948.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.040650746 |
Sensitive |
| ENSG00000231969.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.031270899 |
Sensitive |
| ENSG00000233006.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.041968584 |
Sensitive |
| ENSG00000233029.3 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.039415013 |
Sensitive |
| ENSG00000233237.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.043743809 |
Sensitive |
| ENSG00000233818.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.001712847 |
Sensitive |
| ENSG00000234199.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.041806414 |
Sensitive |
| ENSG00000235180.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.037493906 |
Sensitive |
| ENSG00000235781.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.030600471 |
Sensitive |
| ENSG00000235831.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.015056316 |
Sensitive |
| ENSG00000236514.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.014984714 |
Sensitive |
| ENSG00000236591.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.021901397 |
Sensitive |
| ENSG00000236751.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.016131341 |
Sensitive |
| ENSG00000236799.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.04522113 |
Sensitive |
| ENSG00000237862.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.04643685 |
Sensitive |
| ENSG00000237870.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.023787977 |
Sensitive |
| ENSG00000238042.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.022448315 |
Sensitive |
| ENSG00000239353.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.011519757 |
Sensitive |
| ENSG00000239705.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.032760102 |
Sensitive |
| ENSG00000239828.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.040198459 |
Sensitive |
| ENSG00000242516.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.042197658 |
Sensitive |
| ENSG00000242759.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.043642977 |
Sensitive |
| ENSG00000243243.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.038666656 |
Sensitive |
| ENSG00000243415.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.042901574 |
Sensitive |
| ENSG00000243795.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.0110489 |
Sensitive |
| ENSG00000245275.3 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.010571093 |
Sensitive |
| ENSG00000245573.3 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.023115627 |
Sensitive |
| ENSG00000246273.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.016113887 |
Sensitive |
| ENSG00000246898.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.033988677 |
Sensitive |
| ENSG00000247311.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.013734924 |
Sensitive |
| ENSG00000248223.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.000218291 |
Sensitive |
| ENSG00000248494.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.005703602 |
Sensitive |
| ENSG00000248690.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.008191514 |
Sensitive |
| ENSG00000248693.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.035818327 |
Sensitive |
| ENSG00000249610.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.036703792 |
Sensitive |
| ENSG00000250061.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.048028765 |
Sensitive |
| ENSG00000250303.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.032854617 |
Sensitive |
| ENSG00000251009.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.035854858 |
Sensitive |
| ENSG00000251136.4 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.040993656 |
Sensitive |
| ENSG00000251144.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.026192647 |
Sensitive |
| ENSG00000251194.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.042353834 |
Sensitive |
| ENSG00000251442.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.045422477 |
Sensitive |
| ENSG00000253130.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.024089059 |
Sensitive |
| ENSG00000253374.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.017594333 |
Sensitive |
| ENSG00000253562.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.035401282 |
Sensitive |
| ENSG00000253859.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.006589943 |
Sensitive |
| ENSG00000254397.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.029205263 |
Sensitive |
| ENSG00000254418.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.014434317 |
Sensitive |
| ENSG00000254606.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.049994586 |
Sensitive |
| ENSG00000255089.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.030420136 |
Sensitive |
| ENSG00000255165.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.027741171 |
Sensitive |
| ENSG00000255509.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.043158646 |
Sensitive |
| ENSG00000257261.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.022733671 |
Sensitive |
| ENSG00000257556.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.002910425 |
Sensitive |
| ENSG00000257595.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.038022016 |
Sensitive |
| ENSG00000258736.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.043138642 |
Sensitive |
| ENSG00000258955.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.028518409 |
Sensitive |
| ENSG00000259031.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.020397569 |
Sensitive |
| ENSG00000259146.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.04432683 |
Sensitive |
| ENSG00000259158.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.010885653 |
Sensitive |
| ENSG00000259417.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.00435349 |
Sensitive |
| ENSG00000259450.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.027278062 |
Sensitive |
| ENSG00000259561.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.02463081 |
Sensitive |
| ENSG00000259644.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.026898301 |
Sensitive |
| ENSG00000259727.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.036751832 |
Sensitive |
| ENSG00000259732.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.020934341 |
Sensitive |
| ENSG00000259867.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.031882865 |
Sensitive |
| ENSG00000260051.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.038415266 |
Sensitive |
| ENSG00000260613.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.041155505 |
Sensitive |
| ENSG00000261396.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.023606838 |
Sensitive |
| ENSG00000262686.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.039039205 |
Sensitive |
| ENSG00000262903.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.022101855 |
Sensitive |
| ENSG00000263400.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.006981308 |
Sensitive |
| ENSG00000263466.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.0000958 |
Sensitive |
| ENSG00000264107.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.02977482 |
Sensitive |
| ENSG00000264672.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.036570373 |
Sensitive |
| ENSG00000265519.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.028220967 |
Sensitive |
| ENSG00000266283.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.040339028 |
Sensitive |
| ENSG00000266904.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.03809727 |
Sensitive |
| ENSG00000267009.2 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.047136284 |
Sensitive |
| ENSG00000267219.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.04219449 |
Sensitive |
| ENSG00000267345.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.009266133 |
Sensitive |
| ENSG00000267581.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.031672892 |
Sensitive |
| ENSG00000267934.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.011631686 |
Sensitive |
| ENSG00000268549.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.031935786 |
Sensitive |
| ENSG00000269392.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.021195114 |
Sensitive |
| ENSG00000269481.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.04563911 |
Sensitive |
| ENSG00000269483.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.036831047 |
Sensitive |
| ENSG00000269640.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.049778742 |
Sensitive |
| ENSG00000269895.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.018883368 |
Sensitive |
| ENSG00000269956.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.014539893 |
Sensitive |
| ENSG00000269959.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.040108404 |
Sensitive |
| ENSG00000269966.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.039512072 |
Sensitive |
| ENSG00000270000.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.013338389 |
Sensitive |
| ENSG00000270069.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.032419005 |
Sensitive |
| ENSG00000271020.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.040363536 |
Sensitive |
| ENSG00000271204.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.008867359 |
Sensitive |
| ENSG00000271590.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.047143995 |
Sensitive |
| ENSG00000271643.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.002541316 |
Sensitive |
| ENSG00000271826.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.009591797 |
Sensitive |
| ENSG00000272070.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.003598335 |
Sensitive |
| ENSG00000272088.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.037888519 |
Sensitive |
| ENSG00000272103.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.003294198 |
Sensitive |
| ENSG00000272265.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.02601455 |
Sensitive |
| ENSG00000272668.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.010175789 |
Sensitive |
| ENSG00000273123.1 |
NVP-TAE684 |
Lung squamous cell carcinoma |
0.015680824 |
Sensitive |
